Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
Human Papilloma Virus (HPV), Tetanus-diphtheria-acellular Pertussis (Tdap), Meningococcal Infection
About this trial
This is an interventional prevention trial for Human Papilloma Virus (HPV) focused on measuring adolescent reminder/recall, adolescent vaccines, Tdap, Meningococcal, HPV, Reminder cards, Recall messages, vaccine, conjugate
Eligibility Criteria
Inclusion Criteria:
- children ages 11-18
- seen in practice in last 2 years
- not up-to-date on any or all shots (Tdap, HPV, meningococcal)
- parents agree to participate in Colorado Immunization and Information System registry
Exclusion Criteria:
- up-to-date on all vaccines
- under age 11 over age 18
- patients who have moved or gone elsewhere at each practice setting
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Reminder/recall notices for vaccines
Usual Care
This group will receive up to 4 recall messages (both letters and computer-generated phone messages) reminding them to get their vaccines. There are 4 separate study groups: 1) private pediatric patients 2) public pediatric patients 3) school-based health center patients and 4) family medicine patients.
This group will receive usual care. There are 4 separate study groups: 1) private pediatric patients 2) public pediatric patients 3) school-based health center patients and 4) family medicine patients.